Literature DB >> 9634800

Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently.

B Massie1, J Dionne, N Lamarche, J Fleurent, Y Langelier.   

Abstract

We have constructed a new adenovirus (Ad) expression vector, pAdBM5, that allows for the production of unprecedented levels of recombinant protein in the human 293 cell line using the Ad expression system. The main feature of this vector is a combination of enhancer sequences that increases the activity of the ectopic major late promoter (MLP) in recombinant Ad. In 293 cells infected with helper-free Ad recombinants generated with the pAdBM5 transfer vector, both herpes simplex virus (HSV) ribonucleotide reductase R1 and R2 subunits represent the most abundant polypeptides, accounting for as much as 15-20% of total cellular proteins. Our data suggest that this level of expression is probably very close to the upper limit of the system. Furthermore, when compared to the widely utilized baculovirus (Bac)/Sf9 expression system, the improved Ad vector showed a better performance for the production and purification of active HSV-2 ribonucleotide reductase R1 and R2 subunits. The R2 subunit was about 5-fold more abundant in recombinant Ad-infected 293 cells than in Bac-infected Sf9 cells while the R1 subunit was produced at roughly similar levels with either system. However, the amount of active soluble R1 obtained from recombinant Ad-infected 293 cells was at least 5 times higher because most of the R1 produced in Sf9 cells was insoluble.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9634800     DOI: 10.1038/nbt0695-602

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  13 in total

1.  Radiation inactivation of ribonucleotide reductase, an enzyme with a stable free radical.

Authors:  G Bolger; M Liuzzi; R Krogsrud; E Scouten; R McCollum; E Welchner; E Kempner
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

2.  Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge.

Authors:  Nikolay Korokhov; Galina Mikheeva; Alexander Krendelshchikov; Natalya Belousova; Vera Simonenko; Valentina Krendelshchikova; Alexander Pereboev; Alexander Kotov; Olga Kotova; Pierre L Triozzi; Wayne A Aldrich; Joanne T Douglas; Kin-Ming Lo; Papia T Banerjee; Stephen D Gillies; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Exploiting features of adenovirus replication to support mammalian kinase production.

Authors:  Matt Cotten; Kerstin Stegmueller; Jan Eickhoff; Miriam Hanke; Katrin Herzberger; Thomas Herget; Axel Choidas; Henrik Daub; Klaus Godl
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

4.  New adenovirus vectors for protein production and gene transfer.

Authors:  B Massie; D D Mosser; M Koutroumanis; I Vitté-Mony; L Lamoureux; F Couture; L Paquet; C Guilbault; J Dionne; D Chahla; P Jolicoeur; Y Langelier
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

5.  Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette.

Authors:  B Massie; F Couture; L Lamoureux; D D Mosser; C Guilbault; P Jolicoeur; F Bélanger; Y Langelier
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Production of the R2 subunit of ribonucleotide reductase from herpes simplex virus with prokaryotic and eukaryotic expression systems: higher activity of R2 produced by eukaryotic cells related to higher iron-binding capacity.

Authors:  N Lamarche; G Matton; B Massie; M Fontecave; M Atta; F Dumas; P Gaudreau; Y Langelier
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

Review 7.  Adenovirus-mediated gene transfer into striated muscles.

Authors:  G Acsadi; B Massie; A Jani
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

8.  A short polypeptide from the herpes simplex virus type 2 ICP10 gene can induce antigen aggregation and autophagosomal degradation for enhanced immune presentation.

Authors:  Xinping Fu; Lihua Tao; Xiaoliu Zhang
Journal:  Hum Gene Ther       Date:  2010-12       Impact factor: 5.695

9.  High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells.

Authors:  Yves Durocher; Sylvie Perret; Amine Kamen
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

10.  Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells.

Authors:  A Garnier; J Côté; I Nadeau; A Kamen; B Massie
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.